ETH News
All stories by Oliver Renn
Platinum nanoparticles for selective treatment of liver cancer cells
News
Researchers at ETH Zurich recently demonstrated that platinum nanoparticles can be used to kill liver cancer cells with greater selectivity than existing cancer drugs.